KK
NUVB icon

KLP Kapitalforvaltning’s Nuvation Bio NUVB Stock Holding History

KLP Kapitalforvaltning’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396K Buy
69,800
+22,200
+47% +$109K ﹤0.01% 1614
2026
Q1 		$204K Hold
47,600
– – ﹤0.01% 1805
2025
Q4 		$426K Buy
47,600
+4,100
+9% +$25.4K ﹤0.01% 1489
2025
Q3 		$161K Hold
43,500
– – ﹤0.01% 1895
2025
Q2 		$84.8K Hold
43,500
– – ﹤0.01% 2083
2025
Q1 		$76.6K Hold
43,500
– – ﹤0.01% 2108
2024
Q4 		$116K Buy
+43,500
New +$112K ﹤0.01% 2027

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

KLP Kapitalforvaltning's NUVB Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Nuvation Bio (NUVB) stake by 47% in Q2 2026, buying an estimated $109K and bringing the position to 69,800 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #1614.

KLP Kapitalforvaltning first reported a position in NUVB in Q4 2024 and has held it in 7 quarters since. The position peaked at $426K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • KLP Kapitalforvaltning held 69,800 shares of Nuvation Bio worth $396K as of Q2 2026.
  • KLP Kapitalforvaltning bought 22,200 Nuvation Bio shares in Q2 2026, an estimated $109K.
  • Nuvation Bio made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1614 holding.
  • KLP Kapitalforvaltning first reported a position in Nuvation Bio in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Nuvation Bio position peaked at $426K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.